Virginia M. Stone

659 citations

23 papers · 509 indexed · h-index 13

Cardiology and Cardiovascular Medicine top 10%
Surgery
Infectious Diseases top 10%
Molecular Biology
Genetics

Co-authors: Malin Flodström‐Tullberg Heikki Hyöty Minna M. Hankaniemi Vesa P. Hytönen Olli H. Laitinen Amir‐Babak Sioofy‐Khojine David M. Smith Noel G. Morgan
Topics: Viral Infections and Immunology Research (14 papers)Viral gastroenteritis research and epidemiology (10 papers)Pancreatic function and diabetes (5 papers)
Cited by: Infectious Diseases Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism
Journals: PLoS ONE Diabetes Scientific Reports
Partner nations: Sweden Finland United Kingdom

In The Last Decade

Virginia M. Stone

21 papers receiving 503 citations

Peers

Countries citing papers authored by Virginia M. Stone

Since Specialization

Citations

This map shows the geographic impact of Virginia M. Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia M. Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia M. Stone more than expected).

Fields of papers citing papers by Virginia M. Stone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia M. Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia M. Stone. The network helps show where Virginia M. Stone may publish in the future.

Co-authorship network of co-authors of Virginia M. Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia M. Stone. A scholar is included among the top collaborators of Virginia M. Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia M. Stone. Virginia M. Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Frequent longitudinal blood microsampling and proteome monitoring identify disease markers and enable timely intervention in a mouse model of type 1 diabetes 2025 ·Diabetologia ·Anirudra Parajuli,(unknown),(unknown),Virginia M. Stone,Emma Ringqvist,Marta Butrym,(unknown),(unknown),Stefan Bauer,Niclas Roxhed,Jochen M. Schwenk,Malin Flodström‐Tullberg	0
2	Coxsackie B1 virus-like particle vaccine modified to exclude a highly conserved immunoreactive region from the capsid induces potent neutralizing antibodies and protects against infection in mice 2025 ·Journal of Biomedical Science ·(unknown),(unknown),Virginia M. Stone,(unknown),(unknown),(unknown),T. Haikarainen,Malin Flodström‐Tullberg,Ilkka Junttila,Minna M. Hankaniemi	0
3	Coxsackievirus B infections are common in Cystic Fibrosis and experimental evidence supports protection by vaccination 2022 ·iScience ·Virginia M. Stone,(unknown),Marta Butrym,Amir‐Babak Sioofy‐Khojine,Minna M. Hankaniemi,Emma Ringqvist,Marfa Blanter,Anirudra Parajuli,(unknown),Björn Fischler,Ferenc Karpati,Vesa P. Hytönen,Heikki Hyöty,Lena Hjelte,Malin Flodström‐Tullberg	3
4	Proteome profiling of whole plasma and plasma-derived extracellular vesicles facilitates the detection of tissue biomarkers in the non-obese diabetic mouse 2022 ·Frontiers in Endocrinology ·(unknown),Helena Sork,Virginia M. Stone,Maria Eldh,Xiaofang Cao,Maria Pernemalm,Susanne Gabrielsson,Malin Flodström‐Tullberg	8
5	Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells—A Strategy Used by Coxsackie B Virus to Evade the Host’s Innate Immune Response at the Primary Site of Infection? 2021 ·Microorganisms ·Virginia M. Stone,Emma Ringqvist,Pär Larsson,(unknown),Ulrika Holmlund,Eva Sverremark‐Ekström,Malin Flodström‐Tullberg	8
6	Antibody Responses against Enterovirus Proteases are Potential Markers for an Acute Infection 2020 ·Viruses ·(unknown),Virginia M. Stone,Minna M. Hankaniemi,Magdalena Mazur,Tytti Vuorinen,Malin Flodström‐Tullberg,Heikki Hyöty,Vesa P. Hytönen,Olli H. Laitinen	8
7	Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine 2020 ·Microorganisms ·Minna M. Hankaniemi,Mo Baikoghli,Virginia M. Stone,(unknown),(unknown),(unknown),Amir‐Babak Sioofy‐Khojine,(unknown),(unknown),Brandon J. Anson,Heikki Hyöty,Varpu Marjomäki,Malin Flodström‐Tullberg,R. Holland Cheng,Vesa P. Hytönen,Olli H. Laitinen	15
8	A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates 2020 ·Science Advances ·Virginia M. Stone,Minna M. Hankaniemi,Olli H. Laitinen,Amir‐Babak Sioofy‐Khojine,Ang Lin,(unknown),Magdalena Mazur,Varpu Marjomäki,Karin Loré,Heikki Hyöty,Vesa P. Hytönen,Malin Flodström‐Tullberg	57
9	Short-term CFTR inhibition reduces islet area in C57BL/6 mice 2019 ·Scientific Reports ·Dawood Khan,(unknown),(unknown),Virginia M. Stone,Annie Hasib,(unknown),(unknown),(unknown),Nigel Irwin,James Shaw,Neville H. McClenaghan,Viktória Venglovecz,(unknown),Malin Flodström‐Tullberg,Michael G. White,Catriona Kelly	12
10	Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine 2019 ·Antiviral Research ·Minna M. Hankaniemi,Virginia M. Stone,(unknown),(unknown),Amir‐Babak Sioofy‐Khojine,Varpu Marjomäki,Heikki Hyöty,Vesna Blazevic,Malin Flodström‐Tullberg,Vesa P. Hytönen,Olli H. Laitinen	21
11	A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine 2019 ·Vaccine ·Minna M. Hankaniemi,Virginia M. Stone,Amir‐Babak Sioofy‐Khojine,(unknown),Varpu Marjomäki,Heikki Hyöty,Vesna Blazevic,Olli H. Laitinen,Malin Flodström‐Tullberg,Vesa P. Hytönen	18
12	A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses 2018 ·Scientific Reports ·(unknown),Jutta E. Laiho,Sarah J. Richardson,(unknown),Virginia M. Stone,Varpu Marjomäki,(unknown),Marc S. Horwitz,Amir‐Babak Sioofy‐Khojine,(unknown),Minna M. Hankaniemi,Malin Flodström‐Tullberg,Heikki Hyöty,Vesa P. Hytönen,Olli H. Laitinen	20
13	New Coxsackievirus 2Apro and 3Cpro protease antibodies for virus detection and discovery of pathogenic mechanisms 2018 ·Journal of Virological Methods ·Olli H. Laitinen,Emma Svedin,(unknown),Minna M. Hankaniemi,Pär Larsson,(unknown),Virginia M. Stone,Juha A. E. Määttä,Heikki Hyöty,Vesa P. Hytönen,Malin Flodström‐Tullberg	14
14	A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes 2017 ·Diabetologia ·Virginia M. Stone,Minna M. Hankaniemi,Emma Svedin,Amir‐Babak Sioofy‐Khojine,Sami Oikarinen,Heikki Hyöty,Olli H. Laitinen,Vesa P. Hytönen,Malin Flodström‐Tullberg	49
15	Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model 2017 ·Vaccine ·Minna M. Hankaniemi,Olli H. Laitinen,Virginia M. Stone,Amir‐Babak Sioofy‐Khojine,Juha A. E. Määttä,Pär Larsson,Varpu Marjomäki,Heikki Hyöty,Malin Flodström‐Tullberg,Vesa P. Hytönen	30
16	Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technology 2015 ·Journal of Clinical Virology ·Jutta E. Laiho,Sami Oikarinen,Maarit Oikarinen,Pär Larsson,Virginia M. Stone,Didier Hober,(unknown),Malin Flodström‐Tullberg,Jorma Isola,Heikki Hyöty	12
17	The Beneficial Effects of n-3 Polyunsaturated Fatty Acids on Diet Induced Obesity and Impaired Glucose Control Do Not Require Gpr120 2014 ·PLoS ONE ·Mikael Bjursell,Xiufeng Xu,Therése Admyre,Gerhard Böttcher,(unknown),Ralf Nilsson,Virginia M. Stone,Noel G. Morgan,Yan Y. Lam,Leonard H Storlien,Daniel Lindén,David M. Smith,Mohammad Bohlooly‐Y,Jan Oscarsson	62
18	GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans 2014 ·Diabetologia ·Virginia M. Stone,Shalinee Dhayal,Katy J. Brocklehurst,Carol Lenaghan,Maria Sörhede Winzell,Mårten Hammar,Xiufeng Xu,David M. Smith,Noel G. Morgan	106
19	The cytoprotective effects of oleoylethanolamide in insulin‐secreting cells do not require activation of GPR119 2011 ·British Journal of Pharmacology ·Virginia M. Stone,Shalinee Dhayal,David M. Smith,Carol Lenaghan,Katy J. Brocklehurst,Noel G. Morgan	21
20	POMD11 Cannabinoids are neuroprotective in a human cell culture model of Parkinson's disease 2010 ·Journal of Neurology Neurosurgery & Psychiatry ·Camille Carroll,John Zajicek,C. Oliver Hanemann,Virginia M. Stone,(unknown)	1

About Virginia M. Stone

Virginia M. Stone is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Gastroenterology, having authored 23 papers that have together received 509 indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (14 papers), Viral gastroenteritis research and epidemiology (10 papers) and Pancreatic function and diabetes (5 papers). The work is most often cited by research in Infectious Diseases (154 citations), Cardiology and Cardiovascular Medicine (166 citations) and Endocrinology, Diabetes and Metabolism (120 citations). Virginia M. Stone has collaborated with scholars based in Sweden, Finland and United Kingdom. Frequent co-authors include Malin Flodström‐Tullberg, Heikki Hyöty, Minna M. Hankaniemi, Vesa P. Hytönen, Olli H. Laitinen, Amir‐Babak Sioofy‐Khojine, David M. Smith, Noel G. Morgan, Carol Lenaghan and Katy J. Brocklehurst. Their work appears in journals such as PLoS ONE, Diabetes and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact